Eloxx Pharmaceuticals, Inc. (ELOX) stock
ELOXNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
$10.41−1.33 (-11.33%)
Close on Nov 18, 2026Market cap $70.68MP/E –Yield –
Eloxx Pharmaceuticals market cap
Market capitalization is the share price multiplied by the number of shares outstanding.
Eloxx Pharmaceuticals's market cap was $52.51M on Nov 11, 2026, against $3.89K a year earlier. Over the last 5 years it ranged from $3 to $673.63M, with a median of $33.23M.
Market Cap at the end of each year
| Period | Period end | Value | Change |
|---|---|---|---|
| 2026 | Nov 11, 2026 | $52.51M | +1350556.8% |
| 2025 | Dec 31, 2025 | $3.89K | +129500.0% |
| 2024 | Dec 31, 2024 | $3 | -100.0% |
| 2023 | Dec 29, 2023 | $28.60M | -34.1% |
| 2022 | Dec 30, 2022 | $43.37M | -93.6% |
| 2021 | Dec 31, 2021 | $673.63M | -61.7% |
| 2020 | Dec 31, 2020 | $1.76B | -45.7% |
| 2019 | Dec 31, 2019 | $3.24B | -30.3% |
| 2018 | Dec 31, 2018 | $4.64B | +157.3% |
| 2017 | Dec 29, 2017 | $1.80B | – |
See a number that looks wrong?